CY1108716T1 - Μεθοδος διαγνωσεως της νοσου του alzheimer με βαση μια μορφη μεταγραφης γονιδιου. - Google Patents
Μεθοδος διαγνωσεως της νοσου του alzheimer με βαση μια μορφη μεταγραφης γονιδιου.Info
- Publication number
- CY1108716T1 CY1108716T1 CY20091100076T CY091100076T CY1108716T1 CY 1108716 T1 CY1108716 T1 CY 1108716T1 CY 20091100076 T CY20091100076 T CY 20091100076T CY 091100076 T CY091100076 T CY 091100076T CY 1108716 T1 CY1108716 T1 CY 1108716T1
- Authority
- CY
- Cyprus
- Prior art keywords
- diagnosis
- disease
- alzheimer
- gene
- transmission
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει μία μέθοδο κατασκευής μίας πρότυπης διαγνωστικής μορφής μεταγραφής γονιδίου χαρακτηριστικής μίας νόσου ή καταστάσεως ή σταδίου της σε έναν ευκαρυωτικό οργανισμό με τη χρήση μεταγραφών, οι οποίες εκφράζονται διαφορετικά στη νόσο ή κατάσταση σε κύτταρα από δείγματα απομακρυσμένα από την περιοχή της νόσου, ως ιχνηλάτες του δείγματος νουκλεϊνικού οξέως, μεθόδους διαγνώσεως που χρησιμοποιούν τη μέθοδο και συσκευασίες για την πραγματοποίηση της.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO972006A NO972006D0 (no) | 1997-04-30 | 1997-04-30 | Ny metode for diagnose av sykdommer |
EP03075068A EP1323728B1 (en) | 1997-04-30 | 1998-04-30 | Method of diagnosing Alzheimer' s disease on the basis of a gene transcript pattern |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108716T1 true CY1108716T1 (el) | 2014-04-09 |
Family
ID=19900683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091100076T CY1108716T1 (el) | 1997-04-30 | 2009-01-21 | Μεθοδος διαγνωσεως της νοσου του alzheimer με βαση μια μορφη μεταγραφης γονιδιου. |
Country Status (13)
Country | Link |
---|---|
US (4) | US6720138B2 (el) |
EP (3) | EP0979308B1 (el) |
JP (1) | JP4163758B2 (el) |
AT (2) | ATE286143T1 (el) |
AU (1) | AU7222698A (el) |
CY (1) | CY1108716T1 (el) |
DE (2) | DE69828392T2 (el) |
DK (2) | DK0979308T3 (el) |
ES (2) | ES2316693T3 (el) |
HK (2) | HK1026003A1 (el) |
NO (2) | NO972006D0 (el) |
PT (2) | PT979308E (el) |
WO (1) | WO1998049342A1 (el) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO972006D0 (no) * | 1997-04-30 | 1997-04-30 | Forskningsparken I Aas As | Ny metode for diagnose av sykdommer |
US20050123938A1 (en) * | 1999-01-06 | 2005-06-09 | Chondrogene Limited | Method for the detection of osteoarthritis related gene transcripts in blood |
CA2702148C (en) * | 1999-01-06 | 2014-03-04 | Genenews Inc. | Method of profiling gene expression in a human subject having an infectious disease |
US20040241728A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of lung disease related gene transcripts in blood |
US20040248169A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of obesity related gene transcripts in blood |
US20050003394A1 (en) * | 1999-01-06 | 2005-01-06 | Chondrogene Limited | Method for the detection of rheumatoid arthritis related gene transcripts in blood |
US20040241726A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of allergies related gene transcripts in blood |
US20070031841A1 (en) * | 2001-02-28 | 2007-02-08 | Choong-Chin Liew | Method for the detection of gene transcripts in blood and uses thereof |
US20060134635A1 (en) * | 2001-02-28 | 2006-06-22 | Chondrogene Limited | Method for the detection of coronary artery disease related gene transcripts in blood |
US7473528B2 (en) | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
US20040248170A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of hyperlipidemia related gene transcripts in blood |
US20040265868A1 (en) * | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of depression related gene transcripts in blood |
US6365376B1 (en) * | 1999-02-19 | 2002-04-02 | E. I. Du Pont De Nemours And Company | Genes and enzymes for the production of adipic acid intermediates |
US7005256B1 (en) | 1999-03-10 | 2006-02-28 | Cold Spring Harbor Laboratory | Gene chip technology for determining memory genes |
CA2364877C (en) * | 1999-03-10 | 2013-01-08 | Cold Spring Harbor Laboratory | Gene chip technology for determining memory genes |
CA2371212A1 (en) * | 1999-05-19 | 2000-11-23 | Mitokor | Differential gene expression in specific regions of the brain in neurodegenerative diseases |
ATE503023T1 (de) * | 2001-06-18 | 2011-04-15 | Rosetta Inpharmatics Llc | Diagnose und prognose von brustkrebspatientinnen |
US20050064446A1 (en) * | 2001-11-01 | 2005-03-24 | Minerva Biotechnologies Corporation | Detection of binding species with colloidal and non-colloidal structures |
GB0227238D0 (en) * | 2002-11-21 | 2002-12-31 | Diagenic As | Product and method |
US7217807B2 (en) * | 2002-11-26 | 2007-05-15 | Rosetta Genomics Ltd | Bioinformatically detectable group of novel HIV regulatory genes and uses thereof |
FR2853907B1 (fr) * | 2003-04-18 | 2007-08-03 | Commissariat Energie Atomique | Procede de preparation de fragments d'adn par fragmentation selective d'acides nucleiques et ses applications |
US7888497B2 (en) * | 2003-08-13 | 2011-02-15 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof |
WO2005076939A2 (en) * | 2004-02-09 | 2005-08-25 | University Of Kentucky Research Foundation | Assay and method for diagnosing and treating alzheimer’s disease |
US7593483B2 (en) * | 2004-05-07 | 2009-09-22 | Broadcom Corporation | Nonlinear mapping in digital-to-analog and analog-to-digital converters |
JP5697297B2 (ja) | 2004-05-14 | 2015-04-08 | ロゼッタ ジノミクス リミテッド | マイクロnasおよびその使用 |
US7687616B1 (en) | 2004-05-14 | 2010-03-30 | Rosetta Genomics Ltd | Small molecules modulating activity of micro RNA oligonucleotides and micro RNA targets and uses thereof |
US7795419B2 (en) | 2004-05-26 | 2010-09-14 | Rosetta Genomics Ltd. | Viral and viral associated miRNAs and uses thereof |
EP2290071B1 (en) | 2004-05-28 | 2014-12-31 | Asuragen, Inc. | Methods and compositions involving microRNA |
GB0412301D0 (en) * | 2004-06-02 | 2004-07-07 | Diagenic As | Product and method |
US7867703B2 (en) * | 2004-08-26 | 2011-01-11 | Agilent Technologies, Inc. | Element defined sequence complexity reduction |
US7713693B1 (en) | 2004-09-01 | 2010-05-11 | University Of Louisiana At Monroe | Human cancer cell specific gene transcript |
EP2281888B1 (en) | 2004-11-12 | 2015-01-07 | Asuragen, Inc. | Methods and compositions involving miRNA and miRNA inhibitor molecules |
CA2599589A1 (en) * | 2005-02-07 | 2006-08-17 | Genenews,Inc. | Mild osteoarthritis biomarkers and uses thereof |
US20070082350A1 (en) * | 2005-02-09 | 2007-04-12 | Philip Landfield | Assay and method for diagnosing and treating alzheimer's disease |
US20080075789A1 (en) * | 2006-02-28 | 2008-03-27 | The Regents Of The University Of California | Genes differentially expressed in bipolar disorder and/or schizophrenia |
EP2145001A2 (en) | 2006-09-19 | 2010-01-20 | Asuragen, Inc. | Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
AU2007299828C1 (en) | 2006-09-19 | 2014-07-17 | Interpace Diagnostics, Llc | MicroRNAs differentially expressed in pancreatic diseases and uses thereof |
US20090029868A1 (en) * | 2006-10-31 | 2009-01-29 | Applera Corporation | Expression signature in peripheral blood for detection of aortic aneurysm |
WO2008073915A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Micrornas differentially expressed in leukemia and uses thereof |
EP2104734A2 (en) * | 2006-12-08 | 2009-09-30 | Asuragen, INC. | Mir-20 regulated genes and pathways as targets for therapeutic intervention |
CA2671294A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Mir-21 regulated genes and pathways as targets for therapeutic intervention |
CN101675165A (zh) * | 2006-12-08 | 2010-03-17 | 奥斯瑞根公司 | Let-7微小rna的功能和靶标 |
US20090175827A1 (en) * | 2006-12-29 | 2009-07-09 | Byrom Mike W | miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
US20090232893A1 (en) * | 2007-05-22 | 2009-09-17 | Bader Andreas G | miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
CN101801419A (zh) * | 2007-06-08 | 2010-08-11 | 米尔纳疗法公司 | 作为治疗干预的靶标的miR-34调控的基因和路径 |
WO2009036332A1 (en) | 2007-09-14 | 2009-03-19 | Asuragen, Inc. | Micrornas differentially expressed in cervical cancer and uses thereof |
US20090186015A1 (en) * | 2007-10-18 | 2009-07-23 | Latham Gary J | Micrornas differentially expressed in lung diseases and uses thereof |
US8071562B2 (en) * | 2007-12-01 | 2011-12-06 | Mirna Therapeutics, Inc. | MiR-124 regulated genes and pathways as targets for therapeutic intervention |
WO2009086156A2 (en) * | 2007-12-21 | 2009-07-09 | Asuragen, Inc. | Mir-10 regulated genes and pathways as targets for therapeutic intervention |
US20090263803A1 (en) * | 2008-02-08 | 2009-10-22 | Sylvie Beaudenon | Mirnas differentially expressed in lymph nodes from cancer patients |
US20090253780A1 (en) * | 2008-03-26 | 2009-10-08 | Fumitaka Takeshita | COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER |
US20090258928A1 (en) * | 2008-04-08 | 2009-10-15 | Asuragen, Inc. | Methods and compositions for diagnosing and modulating human papillomavirus (hpv) |
US8258111B2 (en) * | 2008-05-08 | 2012-09-04 | The Johns Hopkins University | Compositions and methods related to miRNA modulation of neovascularization or angiogenesis |
EP2318551A4 (en) * | 2008-08-27 | 2012-10-24 | Lundbeck & Co As H | SYSTEM AND METHOD FOR MEASURING BIOMARKER PROFILES |
US20100179213A1 (en) * | 2008-11-11 | 2010-07-15 | Mirna Therapeutics, Inc. | Methods and Compositions Involving miRNAs In Cancer Stem Cells |
GB201000688D0 (en) | 2010-01-15 | 2010-03-03 | Diagenic Asa | Product and method |
EP3214174B1 (en) | 2010-03-04 | 2019-10-16 | InteRNA Technologies B.V. | A mirna molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with emt |
AU2011274619B2 (en) | 2010-07-06 | 2016-11-10 | Interna Technologies Bv | miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway |
EP2640851A2 (en) | 2010-11-17 | 2013-09-25 | Asuragen, Inc. | Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms |
EP2474617A1 (en) | 2011-01-11 | 2012-07-11 | InteRNA Technologies BV | Mir for treating neo-angiogenesis |
CN103459598B (zh) | 2011-02-03 | 2016-08-10 | 米尔纳医疗股份有限公司 | Mir-124的合成模拟物 |
CA2828532A1 (en) | 2011-02-28 | 2012-11-22 | University Of Iowa Research Foundation | Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender |
US9746458B2 (en) * | 2011-04-27 | 2017-08-29 | Loma Linda University Medical Center | Dynactin subunit p62 biomarker for neurological conditions |
US9644241B2 (en) | 2011-09-13 | 2017-05-09 | Interpace Diagnostics, Llc | Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease |
US20130157884A1 (en) | 2011-10-26 | 2013-06-20 | Asuragen, Inc. | Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts |
EP2771487A1 (en) | 2011-10-27 | 2014-09-03 | Asuragen, INC. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
WO2013064702A2 (en) | 2011-11-03 | 2013-05-10 | Diagenic Asa | Probes for diagnosis and monitoring of neurodegenerative disease |
WO2014007623A1 (en) | 2012-07-03 | 2014-01-09 | Interna Technologies B.V. | Diagnostic portfolio and its uses |
US20140100124A1 (en) | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
EP2971149B1 (en) | 2013-03-15 | 2018-05-09 | Baylor Research Institute | Ulcerative colitis (uc)-associated colorectal neoplasia markers |
CA2907377A1 (en) | 2013-03-15 | 2014-09-18 | Baylor Research Institute | Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
WO2014144666A2 (en) | 2013-03-15 | 2014-09-18 | The University Of Chicago | Methods and compositions related to t-cell activity |
CN111566212A (zh) | 2017-11-03 | 2020-08-21 | 因特尔纳技术有限公司 | miRNA分子,等同物,安塔够妙或其来源用于治疗和/或诊断与神经元缺陷相关的病症和/或疾病或用于神经元生成和/或再生 |
CN113924085A (zh) | 2019-04-12 | 2022-01-11 | 加利福尼亚大学董事会 | 用于增加肌肉量和氧化代谢的组合物和方法 |
WO2024028794A1 (en) | 2022-08-02 | 2024-02-08 | Temple Therapeutics BV | Methods for treating endometrial and ovarian hyperproliferative disorders |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981783A (en) | 1986-04-16 | 1991-01-01 | Montefiore Medical Center | Method for detecting pathological conditions |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5925525A (en) | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5871928A (en) | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
JP2802125B2 (ja) | 1989-06-23 | 1998-09-24 | キヤノン株式会社 | 核酸の検出方法 |
US5614192A (en) * | 1989-07-19 | 1997-03-25 | Connective Therapeutics, Inc. | T cell receptor peptides as therapeutics for immune-related disease |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
DE69214243T2 (de) * | 1991-09-23 | 1997-02-06 | Pfizer | Verfahren für die Detektion von spezifische mRNS und DNS in Zellen |
GB2260811B (en) | 1991-10-23 | 1995-07-05 | Yorkshire Cancer Research Camp | Detection of malignant tumours |
AU691469B2 (en) | 1992-03-04 | 1998-05-21 | Synaptic Pharmaceutical Corporation | DNA encoding taurine and gaba transporters and uses thereof |
US6114114A (en) * | 1992-07-17 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
JPH08502889A (ja) * | 1992-10-29 | 1996-04-02 | トーマス・ジェファーソン・ユニバーシティ | 前立腺癌の微小転移を検出する方法 |
US5633137A (en) | 1992-12-01 | 1997-05-27 | The University Of South Florida | Method for measuring specific gene expression: transcriptional activity per gene dose |
US5677125A (en) | 1994-01-14 | 1997-10-14 | Vanderbilt University | Method of detection and diagnosis of pre-invasive cancer |
WO1997027317A1 (en) | 1996-01-23 | 1997-07-31 | Affymetrix, Inc. | Nucleic acid analysis techniques |
US5830645A (en) * | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US6156502A (en) | 1995-12-21 | 2000-12-05 | Beattie; Kenneth Loren | Arbitrary sequence oligonucleotide fingerprinting |
AU2189397A (en) | 1996-02-08 | 1997-08-28 | Affymetrix, Inc. | Chip-based speciation and phenotypic characterization of microorganisms |
AU4327697A (en) | 1996-08-20 | 1998-03-06 | Motorola, Inc. | Method and apparatus for detecting predetermined molecular structures in a sample |
WO1998024935A1 (en) * | 1996-12-06 | 1998-06-11 | Urocor, Inc. | Diagnosis of disease state using mrna profiles |
US6235474B1 (en) | 1996-12-30 | 2001-05-22 | The Johns Hopkins University | Methods and kits for diagnosing and determination of the predisposition for diseases |
US6190857B1 (en) * | 1997-03-24 | 2001-02-20 | Urocor, Inc. | Diagnosis of disease state using MRNA profiles in peripheral leukocytes |
NO972006D0 (no) * | 1997-04-30 | 1997-04-30 | Forskningsparken I Aas As | Ny metode for diagnose av sykdommer |
US5994076A (en) | 1997-05-21 | 1999-11-30 | Clontech Laboratories, Inc. | Methods of assaying differential expression |
WO1999006831A2 (en) | 1997-07-29 | 1999-02-11 | Dorssers Lambert C J | Breast cancer resistance genes, methods for their detection and uses thereof |
US6607879B1 (en) * | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
ATE347102T1 (de) | 1998-02-25 | 2006-12-15 | Us Health | Zellulare anordnungen für schnelle molekulare profilidentifizierung |
US6004755A (en) | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
MXPA01001894A (es) | 1998-08-21 | 2002-04-24 | Naxcor | Ensayos utilizando acidos nucleicos inmovilizados reticulables. |
US6593084B2 (en) | 1998-10-13 | 2003-07-15 | Robert E. Bird | Carcinogen assay |
US20010055760A1 (en) | 1998-10-13 | 2001-12-27 | Alex Chenchik | Nucleic acid arrays |
WO2000024940A1 (en) | 1998-10-28 | 2000-05-04 | Vysis, Inc. | Cellular arrays and methods of detecting and using genetic disorder markers |
WO2000026412A1 (en) | 1998-11-02 | 2000-05-11 | Kenneth Loren Beattie | Nucleic acid analysis using sequence-targeted tandem hybridization |
US7473528B2 (en) * | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
US20040265869A1 (en) * | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of type II diabetes related gene transcripts in blood |
US20050042630A1 (en) * | 1999-01-06 | 2005-02-24 | Chondrogene Limited | Method for the detection of asthma related gene transcripts in blood |
CA2702148C (en) * | 1999-01-06 | 2014-03-04 | Genenews Inc. | Method of profiling gene expression in a human subject having an infectious disease |
US20040241727A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of schizophrenia related gene transcripts in blood |
US20040248170A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of hyperlipidemia related gene transcripts in blood |
US20050003394A1 (en) * | 1999-01-06 | 2005-01-06 | Chondrogene Limited | Method for the detection of rheumatoid arthritis related gene transcripts in blood |
US20040241726A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of allergies related gene transcripts in blood |
US20040265868A1 (en) * | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of depression related gene transcripts in blood |
US20040241728A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of lung disease related gene transcripts in blood |
US20040248169A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of obesity related gene transcripts in blood |
US20020169560A1 (en) * | 2001-05-12 | 2002-11-14 | X-Mine | Analysis mechanism for genetic data |
-
1997
- 1997-04-30 NO NO972006A patent/NO972006D0/no unknown
-
1998
- 1998-04-30 PT PT98919350T patent/PT979308E/pt unknown
- 1998-04-30 DE DE69828392T patent/DE69828392T2/de not_active Expired - Lifetime
- 1998-04-30 DE DE69840154T patent/DE69840154D1/de not_active Expired - Lifetime
- 1998-04-30 EP EP98919350A patent/EP0979308B1/en not_active Expired - Lifetime
- 1998-04-30 PT PT03075068T patent/PT1323728E/pt unknown
- 1998-04-30 WO PCT/GB1998/001261 patent/WO1998049342A1/en active IP Right Grant
- 1998-04-30 AU AU72226/98A patent/AU7222698A/en not_active Abandoned
- 1998-04-30 JP JP54675698A patent/JP4163758B2/ja not_active Expired - Fee Related
- 1998-04-30 EP EP08015742A patent/EP2050825A1/en not_active Withdrawn
- 1998-04-30 AT AT98919350T patent/ATE286143T1/de active
- 1998-04-30 AT AT03075068T patent/ATE412003T1/de active
- 1998-04-30 ES ES03075068T patent/ES2316693T3/es not_active Expired - Lifetime
- 1998-04-30 DK DK98919350T patent/DK0979308T3/da active
- 1998-04-30 EP EP03075068A patent/EP1323728B1/en not_active Expired - Lifetime
- 1998-04-30 ES ES98919350T patent/ES2230688T3/es not_active Expired - Lifetime
- 1998-04-30 DK DK03075068T patent/DK1323728T3/da active
-
1999
- 1999-10-29 US US09/429,003 patent/US6720138B2/en not_active Expired - Fee Related
-
2000
- 2000-08-16 HK HK0105132A patent/HK1026003A1/xx not_active IP Right Cessation
-
2003
- 2003-12-05 US US10/727,576 patent/US20040121390A1/en not_active Abandoned
- 2003-12-31 HK HK03109502.9A patent/HK1057217A1/xx not_active IP Right Cessation
-
2004
- 2004-01-27 NO NO20040371A patent/NO327084B1/no not_active IP Right Cessation
-
2005
- 2005-06-10 US US11/149,370 patent/US20050227286A1/en not_active Abandoned
-
2009
- 2009-01-21 CY CY20091100076T patent/CY1108716T1/el unknown
-
2013
- 2013-07-01 US US13/932,615 patent/US20130337446A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE286143T1 (de) | 2005-01-15 |
HK1057217A1 (en) | 2004-03-19 |
EP2050825A1 (en) | 2009-04-22 |
ATE412003T1 (de) | 2008-11-15 |
EP1323728A3 (en) | 2004-02-04 |
ES2316693T3 (es) | 2009-04-16 |
EP0979308B1 (en) | 2004-12-29 |
DE69840154D1 (de) | 2008-12-04 |
US20130337446A1 (en) | 2013-12-19 |
US6720138B2 (en) | 2004-04-13 |
DE69828392D1 (de) | 2005-02-03 |
PT1323728E (pt) | 2009-01-23 |
HK1026003A1 (en) | 2000-12-01 |
DK1323728T3 (da) | 2009-03-02 |
NO972006D0 (no) | 1997-04-30 |
US20050227286A1 (en) | 2005-10-13 |
DK0979308T3 (da) | 2005-04-18 |
JP4163758B2 (ja) | 2008-10-08 |
ES2230688T3 (es) | 2005-05-01 |
EP0979308A1 (en) | 2000-02-16 |
NO20040371L (no) | 1999-12-14 |
JP2001526534A (ja) | 2001-12-18 |
WO1998049342A1 (en) | 1998-11-05 |
EP1323728A2 (en) | 2003-07-02 |
NO327084B1 (no) | 2009-04-20 |
PT979308E (pt) | 2005-03-31 |
US20020022222A1 (en) | 2002-02-21 |
AU7222698A (en) | 1998-11-24 |
DE69828392T2 (de) | 2005-12-01 |
US20040121390A1 (en) | 2004-06-24 |
EP1323728B1 (en) | 2008-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108716T1 (el) | Μεθοδος διαγνωσεως της νοσου του alzheimer με βαση μια μορφη μεταγραφης γονιδιου. | |
WO2000077260A8 (en) | Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms | |
EP0774518A3 (en) | Nucleic acid probes complementary to Human Papillomavirus nucleic acid and related methods and kits | |
DE69034177D1 (de) | Verfahren zur Amplifikation von Nukleinsäuresequenzen | |
WO2000055368A3 (en) | Probe/mobility modifier complexes for multiplex nucleic acid detection | |
DE69632466D1 (de) | Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen | |
DE69433487D1 (de) | Methoden und zusammensetzungen zur effizienten nukleinsaeuresequenzierung | |
DE60035691D1 (de) | Verfahren zur Erkennung von Einzel-Nukleotid-Polymorphismen | |
WO2002022879A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
DE60143314D1 (de) | Estimmung der präsenz von cryptosporidium organismen in einer testprobe | |
DE69815370D1 (de) | Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen | |
WO2000070340A3 (en) | Materials and methods relating to disease diagnosis | |
WO2005027710A3 (en) | Methods for identifying subjects at risk of melanoma and treatments thereof | |
DE60025336D1 (de) | Verfahren und kit zur früherkennung von krebs | |
DE69535023D1 (de) | Ein diagnose-verfahren und ein testsatz für die bestimmung des kell blutgruppln-nenotyps | |
DE59711887D1 (de) | Dna zur abschätzung des progressionspotentials von zervixläsionen | |
ATE369426T1 (de) | Nukleinsäure- und aminosäuresequenzen von durch hämoglobin induzierbaren genen aus candida albicans und die verwendung dieser sequenzen in reagenzien zur diagnose von disseminierten candida albicans infektionen | |
DE60237406D1 (de) | Aus einem Neuroblastom isolierte Nukleinsäuren | |
EP1431401A3 (fr) | Méthode de détection et/ou de quantification d'une fonction connue à partir d'un échantillon d'acides nucléiques | |
WO1999024607A3 (en) | DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI) | |
WO1998015650A3 (en) | Hydronephrosis gene (hng) and its use |